Navigation Links
LA BioMed researcher to receive prestigious honor
Date:9/27/2010

The American Association of Cardiovascular and Pulmonary Rehabilitation will bestow one of its highest honors on Los Angeles Biomedical Research Institute (LA BioMed) principal investigator, Richard Casaburi, PhD, MD, at the association's annual meeting in Milwaukee.

Dr. Casaburi, who holds the Alvin Grancell/Mary Burns Endowed Chair in the Rehabilitative Sciences at LA BioMed and leads its pulmonary rehabilitation research, will receive the Michael L. Pollock Established Investigator Award on Oct. 8 at the association's 25th Anniversary Celebration Banquet during its Annual Meeting in Milwaukee. In announcing the award, the association said it was recognizing Dr. Casaburi's "many outstanding contributions to cardiovascular and pulmonary rehabilitation."

The association, comprised of health professionals in the field of cardiac and pulmonary rehabilitation, is dedicated to reducing morbidity, mortality and disability from cardiovascular and pulmonary disease through education, prevention, rehabilitation, research and disease management.

"Congratulations to Dr. Casaburi for another milestone in his prestigious career in the field of respiratory research and pulmonary rehabilitation," said David I. Meyer, LA BioMed president and CEO. "Dr. Casaburi has led the way in developing new rehabilitation strategies for the millions suffering from respiratory disease. His research is another example of how LA BioMed's researchers are making a difference in the health and quality of life of patients around the world."

In addition to the Pollock award, Dr. Casaburi has received the California Medal from the American Lung Association of California; the Governors Award from the American College of Chest Physicians; the Mary Burns Award from the California Society for Pulmonary Rehabilitation; the Career Achievement Award from the Fourth Quebec International Symposium on Cardiopulmonary Prevention and Rehabilitation and an award from the American Thoracic Society for his contribution to the establishment of the society's Pulmonary Rehabilitation Assembly.

He is president of the Pulmonary Education and Research Foundation, a nonprofit corporation dedicated to advancing the scientific basis and practice of pulmonary rehabilitation. To date, he has authored 207 publications and 184 abstracts.

At LA BioMed, Dr. Casaburi directs the Rehabilitation Clinical Trials Center, a facility dedicated to performing clinical research aimed at improving the lives of patients with Chronic Obstructive Pulmonary Disease, the fourth leading cause of death in the United States.

In addition to his work at LA BioMed, Dr. Casaburi is associate chief for Research and professor of medicine in the Division of Respiratory and Critical Care Physiology and Medicine at Harbor-UCLA Medical Center. He is also director of Clinical Respiratory Physiology.

He received his PhD from Rensselaer Polytechnic Institute, before qualifying in medicine from the University of Miami, School of Medicine.

He is a Fellow of the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation, and he is a member of the American Physiological Society and the American Thoracic Society. Dr. Casaburi currently serves on the editorial boards of the Journal of Cardiopulmonary Rehabilitation, Proceedings of the American Thoracic Society and the Journal of COPD.


'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
2. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
3. First Annual Bay Area Biomedical Device Conference to be Held at San Jose State University
4. Seattle BioMed Offers the Gift of Hope for Mother's Day
5. LA BioMed awarded research grant to study HIV prevention gel
6. Cambridge Healthtech Institute to Host Its Second Annual Collaborative Innovation in Biomedicine Conference
7. New Diagnostic Testing Company, Blue Ocean Biomedical, Specializes In Automated, Load & Go Cell Analysis Systems For Immune Monitoring
8. Manmade antibodies hold biomedical promise
9. Applied nuclear physics for biomedicine, nuclear security and basic science
10. Blue Ocean Biomedical Opens New Manufacturing Facility In Miramar, FL
11. Team led by LA BioMed scientist develops novel approach to study neurological disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed researcher to receive prestigious honor
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Journey to Christmas:” a beautiful and enchanting tale that teaches ... Kimberly Cordoves, a mother of three in Oklahoma City, and a devoted woman of faith. ... a book has been in the back of my mind for years, but actually doing ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... Management System: an On-demand E-learning system for Clinical and Regulatory education for ... is based on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots , ... from around the world, announces the launch of its newly redesigned website. The ... to research breakthroughs and trending news, vital information on upcoming virtual events and ...
(Date:1/19/2017)... ... January 19, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it will be co-hosting a ... innovative excipients and drug delivery solutions to health industries worldwide. The one day ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. ... results for the fourth quarter of 2016 on Wednesday, February 15, ... ... PM ET on Wednesday, February 15, 2017, during which management will ... other corporate activities. To participate in the conference call, please dial ...
(Date:1/19/2017)... , Jan. 19, 2017 This report on ... and future scenario of the global market. Large number ... consumption. Severe chronic constipation is a major side effect ... laxatives. Hence, novel targeted therapy has been prescribed to ... launch of targeted medicines, and growing awareness about the ...
(Date:1/19/2017)... BOSTON , Jan. 19, 2017  Stealth BioTherapeutics ... therapeutics to treat mitochondrial dysfunction, today announced new additions ... , M.D., as Chief Medical Officer, and Daniel ... Stealth announced that Jim Carr , Pharm.D. has ... "We are pleased to welcome Doug and Daniel ...
Breaking Medicine Technology: